Table 5.
Parameter | Day | C | Hmix | Zn | Hmix+Zn | SD | Significance of effects | ||
---|---|---|---|---|---|---|---|---|---|
Treatment | Time | Treatment × time | |||||||
SAA | 7 | 13.7 | 18.8 | 17.6 | 20.7 | 5.10 | * | NS | * |
(μg/mL) | 35 | 17.9 | 15.4 | 23.7 | 14.2 | 5.20 | |||
49 | 17.9 | 16.9 | 22.9 | 18.6 | 4.12 | ||||
Calpro | 7 | 49.1 | 49.1 | 48.5 | 44.7 | 4.70 | NS | NS | NS |
(ng/mL) | 35 | 46.9 | 38.5 | 50.0 | 49.0 | 9.93 | |||
49 | 41.9 | 42.4 | 48.3 | 45.9 | 10.86 | ||||
IgA | 7 | 0.287 | 0.234 | 0.328 | 0.211 | 0.0642 | ** | NS | NS |
(mg/mL) | 35 | 0.309 | 0.298 | 0.369 | 0.309 | 0.0572 | |||
49 | 0.224 | 0.315 | 0.360 | 0.204 | 0.0842 | ||||
70 | 0.289 | 0.318 | 0.415 | 0.313 | 0.1124 |
C control, Hmix Herbmix, Zn Zn-glycinate, Hmix + Zn Herbmix and Zn-glycinate, NS not significant, SAA serum amyloid A, Calpro calprotectin, IgA immunoglobulin A
* P < 0.05